In post-mortem investigations, it was discovered that MDD patients had reduced Raf-ERK1/2 signaling in the PFC and hippocampus, as well as decreased hippocampal MEK5-ERK5 signaling [49,50]. This evidence concerns the gene MAP2K5 and major depressive disorder.